Cancer Stem Cell-like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small cell lung cancer treated with pembrolizumab
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD‑L1during osimertinib treatment in NSCLC patients
Proficiency testing to assess technical performance for CTC-processing and detection methods in CANCER-ID
Antigen-agnostic microfluidics based circulating tumor cell enrichment and downstream molecular characterization
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients